Spread to the Liver
The liver is a common place for several cancers to spread. What happens next depends on where the cancer began, how much of the liver is involved, whether cancer is anywhere else, your liver function, tumor biology and what treatments you have already had.
Cancer that spreads to the liver is not automatically primary liver cancer.
If colorectal, breast, lung, pancreatic, neuroendocrine or another cancer spreads to the liver, it is still the cancer where it began. That matters because the original cancer and its biomarkers help guide systemic treatment—and the pattern of cancer in the liver can open additional conversations about liver-directed treatment.
Three things can change the conversation.
Where is the cancer?
Is cancer only in the liver, mostly in the liver, or also in other organs? The answer can affect whether local treatment belongs in the discussion.
What is happening inside the liver?
Number, size, location and relationship to major blood vessels and bile ducts matter. So does how much healthy liver can be preserved.
What cancer are we treating?
The cancer of origin and its biomarkers still matter. Systemic therapy is chosen for that cancer—not simply because it is now in the liver.
Call your care team about new or worsening symptoms.
Yellowing of the skin or eyes, increasing belly swelling, significant new right-upper-abdominal pain, repeated vomiting, fever, unusual sleepiness or confusion deserve prompt medical attention. Severe or rapidly worsening symptoms may require urgent evaluation.
Treatment may have two jobs.
Treat the cancer throughout the body
Systemic treatment may include chemotherapy, targeted therapy, immunotherapy, endocrine therapy or other cancer-specific treatments depending on where the cancer began and its biology.
Treat what is happening in the liver
For selected patients, surgery, ablation, radiation or catheter-based liver-directed treatments may be considered—sometimes alongside systemic therapy and sometimes in sequence with it.
Four doors worth opening.
A medical oncologist may lead your overall treatment, but liver involvement can be a reason to bring additional expertise to the table.
Medical Oncology
Connects the original cancer, biomarkers, prior treatments and disease everywhere in the body into the systemic treatment plan.
Hepatobiliary Surgery
Selected liver metastases can sometimes be removed surgically. Resectability depends on much more than simply counting tumors.
Interventional Oncology
Depending on the cancer and liver pattern, an interventional radiologist may evaluate ablation or catheter-based treatments delivered through the liver's blood supply.
Radiation Oncology
Highly focused radiation such as SBRT may be considered for selected patients when local control of one or more liver tumors is important.
“Liver-directed treatment” is not one treatment.
Different approaches solve different problems. Which ones are reasonable depends on the original cancer, tumor location and volume, liver function, disease outside the liver, prior treatments and the experience of the treating center.
Use the RoadMap as your guide.
Some liver tumors that cannot be removed at one point may become removable after treatment, and some patients who are not surgical candidates may have other liver-directed possibilities. The useful question is: “Has my case been reviewed by a multidisciplinary liver team?”
You are allowed to ask “What else?”
A liver scan is a picture—not the whole plan.
One specialist may see systemic treatment. Another may see something removable. Another may see something they can ablate, radiate or reach through an artery. Sometimes hope begins when the same scan is looked at through more than one set of eyes.